Vascular endothelial growth factor induces protein synthesis in renal epithelial cells: A potential role in diabetic nephropathy

Kidney International

Volumn 64, Issue 2, 2003, Pages 468-479

  Senthil, Duraisamy ^b   Choudhury, Goutam Ghosh ^b   McLaurin, Colby ^b   Kasinath, Balakuntalam S ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b NONE

Author keywords

Growth factors; Protein translation; Renal hypertrophy

Indexed keywords

ALANINE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; STREPTOZOCIN; THREONINE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENZYME ACTIVITY; EPITHELIUM CELL; GENETIC TRANSFECTION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY CORTEX; KIDNEY EPITHELIUM; KIDNEY HYPERTROPHY; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; REGULATORY MECHANISM;

EID: 0037707375     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00135.x     Document Type: Article

References (48)

1. FELIERS D, SENTHIL D, FAULKNER JL, et al: Activation of renal signaling pathways in db/db mice with type 2 diabetes. Kidney Int 60:495-504, 2001
2. AIELLO LP, AVERY RL, ARRIGG PG, et al: Vascular endothelial growth factors in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480-1487, 1994
3. SMITH LE, WESOLOWSKI E, MCLELLAN A, et al: Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35:101-111, 1994
4. AIELLO LP, PIERCE EA, FOLEY ED, et al: Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci USA 92:10457-10461, 1995
5. ADAMIS AP, SHIMA DT, TOLENTINO MJ, et al: Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. Arch Ophthalmol 114:66-71, 1996
6. ROBINSON GS, PIERCE EA, ROOK SL, et al: Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy. Proc Natl Acad Sci USA 93:4851-4856, 1996
7. COOPER ME, VRANES D, YOUSSEF S, et al: Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes. Diabetes 48:2229-2239, 1999
8. TSUCHIDA K, MAKITA Z, YAMAGISHI S, et al: Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195. Diabetologia 42:579-588, 1999
9. DE VRIESE AS, TILTON RG, ELGER M, et al: Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J Am Soc Nephrol 12:993-1000, 2001
10. WATERS KM, NTAMBI JM: Insulin and dietary fructose induce stearoyl-CoA desaturase 1 gene expression of diabetic mice. J Biol Chem 269:27773-27777, 1994
11. BHANDARI B, FELIERS D, SENTHIL D, et al: Insulin regulation of protein translation repressor 4E-BP1 an eIF4E binding protein, in renal epithelial cells. Kidney Int 59:866-875, 2001
12. SENTHIL D, FAULKNER JL, CHOUDHURY GG, et al: Angiotensin II inhibits insulin-stimulated phosphorylation of eukaryotic initiation factor 4E-binding protein-1 in proximal tubular epithelial cells. Biochem J 360:87-95, 2001
13. HAVERTY TP, KELLY CJ, HINES WH, et al: Characterization of a renal tubular epithelial cell line which secretes the autologous target antigen of autoimmune experimental interstitial nephritis. J Cell Biol 107:1359-1368, 1988
14. FUJIO Y, GUO K, MANO T, et al: Cell cycle withdrawal promotes myogenic induction of Akt, a positive modulator of myocyte survival. Mol Cell Biol 19:5073-5082, 1999
15. CHOUDHURY GG: Akt serine threonine kinase regulates platelet-derived growth factor-induced DNA synthesis in glomerular mesangial cells: regulation of c-fos AND p27 (kip1) gene expression. J Biol Chem 276:35636-35643, 2001
16. GINGRAS AC, GYGI SP, RAUGHT B, et al: Regulation of 4E-BP1 phosphorylation: A novel two-step mechanism. Genes Dev 13:1422-1437, 1999
17. CROSS MJ, CLAESSON-WELSH L: FGF and VEGF function in angiogenesis: Signalling pathways, biological responses and therapeutic inhibition. Trends Pharmacol Sci 22:201-207, 2001
18. MENDEZ R, KOLLMORGEN G, WHITE MF, RHOADS RE: Requirement of protein kinase C zeta for stimulation of protein synthesis by insulin. Mol Cell Biol 17:5184-5192, 1997
19. GORIN Y, KIM NH, FELIERS D, et al: Angiotensin II activates Akt/protein kinase B by an arachidonic acid/redox-dependent pathway and independent of phosphoinositide 3-kinase. FASEB J 15:1909-1920, 2001
20. GINGRAS AC, RAUGHT B, SONENBERG N: eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu Rev Biochem 68:913-963, 1999
21. MIRON M, SONENBERG N: Regulation of translation via TOR signaling: Insights from Drosophila melanogaster. J Nutr 131:2988S-2993S, 2001
22. BACIC M, EDWARDS NA, MERRILL MJ: Differential expression of vascular endothelial growth factor (vascular permeability factor) forms in rat tissues. Growth Factors 12:11-15, 1995
23. BROWN LF, BERSE B, TOGNAZZI K, et al: Vascular permeability factor mRNA and protein expression in human kidney. Kidney Int 42:1457-1461, 1992
24. KIM YG, SUGA SI, KANG DH, et al: Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy. Kidney Int 58:2390-2399, 2000
25. GRONE HJ, SIMON M, GRONE EF: Expression of vascular endothelial growth factor in renal vascular disease and renal allografts. J Pathol 177:259-267, 1995
26. EL AWAD B, KREFT B, WOLBER EM, et al: Hypoxia and interleukin-1beta stimulate vascular endothelial growth factor production in human proximal tubular cells. Kidney Int 58:43-50, 2000
27. CHA DR, KIM NH, YOON JW, et al: Role of vascular endothelial growth factor in diabetic nephropathy. Kidney Int 77:S104-S112, 2000
28. PUPILLI C, LASAGNI L, ROMAGNANI P, et al: Angiotensin II stimulates the synthesis and secretion of vascular permeability factor/vascular endothelial growth factor in human mesangial cells. J Am Soc Nephrol 10:245-255, 1999
29. PERTOVAARA L, KAIPAINEN A, MUSTONEN T, et al: Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. J Biol Chem 269:6271-6274, 1994
30. MATSUMOTO T, CLAESSON-WELSH L: VEGF receptor signal transduction. Sci STKE 112:RE21, 2001
31. SIMON M, GRONE HJ, JOHREN O, et al: Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney. Am J Physiol 268:F240-F250, 1995
32. ZACHARY I, GLIKI G: Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. Cardiovasc Res 49:568-581, 2001
33. WHITE MF, YENUSH L: The IRS-signaling system: A network of docking proteins that mediate insulin and cytokine action. Curr Top Microbiol Immunol 228:179-208, 1998
34. SENTHIL D, CHOUDHURY GG, BHANDARI BK, KASINATH BS: The type 2 vascular endothelial growth factor receptor recruits insulin receptor substrate-1 in its signaling pathway. Biochem J 368:49-56, 2002
35. SENTHIL D, CHOUDHURY GG, ABBOUD HE, et al: Regulation of protein synthesis by IGF-I in proximal tubular epithelial cells. Am J Physiol Renal Physiol 283:F1226-F1236, 2002
36. BRUNN GJ, HUDSON CC, SEKULIC A. et al: Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. Science 277:99-101, 1997
37. MOTHE-SATNEY I, YANG D, FADDEN P, et al: Multiple mechanisms control phosphorylation of PHAS-I in five (S/T)P sites that govern translational repression. Mol Cell Biol 20:3558-3567, 2000
38. HEESOM KJ, GAMPEL A, MELLOR H, DENTON RM: Cell cycle-dependent phosphorylation of the translational repressor eIF-4E binding protein-1 (4E-BP1). Curr Biol 11:1374-1379, 2001
39. YANG DQ, KASTAN MB: Participation of ATM in insulin signalling through phosphorylation of eIF-4E-binding protein 1. Nat Cell Biol 2:893-898, 2000
40. NAVE BT, OUWENS M, WITHERS DJ, et al: Mammalian target of rapamycin is a direct target for protein kinase B: Identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation. Biochem J 344:427-431, 1999
41. WASKIEWICZ AJ, FLYNN A, PROUD CG, COOPER JA: Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2. EMBO J 16:1909-1920, 1997
42. FLYVBJERG A, DAGNAES-HANSEN F, DE VRIESE AS, et al: Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody. Diabetes 51:3090-3094, 2002
43. FLYVBJERG A, SCHRIJVERS BF, DE VRIESE AS, et al: Compensatory glomerular growth after unilateral nephrectomy is VEGF dependent. Am J Physiol Endocrinol Metab 283:E362-E366, 2002
44. SCHRIJVERS BF, RASCH R, TILTON RG, FLYVBJERG A: High protein-induced glomerular hypertrophy is vascular endothelial growth factor-dependent. Kidney Int 61:1600-1604, 2002
45. FLYVBJERG A: Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease. Diabetologia 43:1205-1223, 2000
46. KANG DH, HUGHES J, MAZZALI M, et al: Impaired angiogenesis in the remnant kidney model. II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. J Am Soc Nephrol 12:1448-1457, 2001
47. REMUZZI G, BENIGNI A: Repairing renal lesions: Will VEGF be the builder? Kidney Int 58:2594-2595, 2000
48. CONNOLLY DT, OLANDER JV, HEUVELMAN D, et al: Human vascular permeability factor. Isolation from U937 cells. J Biol Chem 264:20017-20024, 1989